| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 01/03/2001 | EP1065208A1 Substituted purine derivatives as inhibitors of cell adhesion |
| 01/03/2001 | EP1065207A1 Naphthyridine derivatives, processes for their preparation, their use, and pharmaceutical compositions comprising them |
| 01/03/2001 | EP1065203A2 Heterocyclic compounds as retinoic acid receptor antagonists |
| 01/03/2001 | EP1064403A1 Antisense modulation of pecam-1 |
| 01/03/2001 | EP1064402A1 Antisense modulation of lfa-3 |
| 01/03/2001 | EP1064382A2 Polypeptides homologous to vegf and bmp1 |
| 01/03/2001 | EP1064380A1 EXPRESSION OF THE $i(INSL4) GENE IN HUMAN EMBRYONIC BONE TISSUES AND APPLICATIONS |
| 01/03/2001 | EP1064308A1 Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses |
| 01/03/2001 | EP1064298A2 Inhibitors of caspases |
| 01/03/2001 | EP1064289A1 Heterocyclic signal transduction inhibitors, compositions containing them |
| 01/03/2001 | EP1064277A1 2-(2,6-dioxopiperidin-3-yl)isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines |
| 01/03/2001 | EP1064269A1 Barbituric acid derivative and preventive and therapeutic agent for bone and cartilage containing the same |
| 01/03/2001 | EP1064018A2 The use of isolated domains of type iv collagen to modify cell and tissue interactions |
| 01/03/2001 | EP1064016A2 Compositions for modulating cell differentiation comprising a lipid and a morphogen |
| 01/03/2001 | EP1064009A1 Utilization of extracts from iris plants, cimicifuga racemosa and tectorigenin as an estrogen-like organ-selective medicament without uterotropic effects |
| 01/03/2001 | EP1063987A1 Dietary control of arachidonic acid metabolism |
| 01/03/2001 | EP1063985A1 Benzoates derivatives for inhibiting angiogenesis |
| 01/03/2001 | EP0842169B1 Benzothiophene compounds |
| 01/03/2001 | EP0815126B1 Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition |
| 01/03/2001 | EP0807183B1 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle |
| 01/03/2001 | CN1278812A 2-aryl-3-aroylbenzo [b] thiophenes for treatment of estrin deficiency |
| 01/03/2001 | CN1278811A 2-Arylbenzo[b] thiophenes useful for the treatment of estrogen deprivtion syndrome |
| 01/03/2001 | CN1278806A Aminothiazole inhibitors of cyclin dependent protein kinasses of cells |
| 01/03/2001 | CN1278802A Benzoxazine and Benzothiazine derivatives and their use in pharmaceuticals |
| 01/03/2001 | CN1278790A Chemical compound |
| 01/03/2001 | CN1278789A 9,10-Dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors |
| 01/03/2001 | CN1278734A Methods and compositions for treating rheumatoid arthritis |
| 01/03/2001 | CN1278726A IL-8 receptor antagonists |
| 01/03/2001 | CN1278725A Indeno [1,2-c]-naphtho [1,2-C]- and benzo [6,7] cyclohepta [1,2-C] pyrazole derivatives |
| 01/03/2001 | CN1278724A Indeno [1,2-c] pyrazole derivatives for inhibiting tyrosine kinase activty |
| 01/03/2001 | CN1278721A IL-8 receptor antagonists |
| 01/03/2001 | CN1278530A Novel peptide derivative |
| 01/03/2001 | CN1060163C Acylated aminoalknimidazoles and aminoalkyl triazoles |
| 01/03/2001 | CN1060088C Plaster for treating bone, joint, nerve and musde diseases and preparation method thereof |
| 01/03/2001 | CN1060076C Chinese patent medicine for treating hyperosteogey and preparation method thereof |
| 01/03/2001 | CN1060074C Chinese patent drug for treating diabetes and gout |
| 01/03/2001 | CN1060056C Adhesive plaster for curing osteomyelitis |
| 01/03/2001 | CN1060048C Snake spirit for rheumatism and its preparation |
| 01/03/2001 | CN1060045C Positive molecular bone intensifying agent and its producing technology |
| 01/02/2001 | US6169090 Heterocyclic compounds and their therapeutic use |
| 01/02/2001 | US6169087 An enzyme inhibitor for treating type i diabetes, type ii diabetes, impaired glucose tolerance, insulin resistance, obesity, autoimmune diseases, diseases with dysfunctions of the coagulation system, allergic diseases, cancer, psoriasis |
| 01/02/2001 | US6169072 Cyclic adhesion inhibitors |
| 01/02/2001 | US6168933 Nucleotide sequences coding a transport protein; for the classification, diagnosis, prevention, and treatment of defects in cell proliferation, lipid metabolism and transport |
| 12/28/2000 | WO2000078953A2 Human transport proteins |
| 12/28/2000 | WO2000078952A2 Human rna metabolism proteins (rmep) |
| 12/28/2000 | WO2000078815A1 ANTI-αvβ3? RECOMBINANT HUMAN ANTIBODIES, NUCLEIC ACIDS ENCODING SAME AND METHODS OF USE |
| 12/28/2000 | WO2000078794A1 Cysteinyl protease inhibitors |
| 12/28/2000 | WO2000078766A1 Difuropyrone derivatives |
| 12/28/2000 | WO2000078731A1 5-cyano-2-aminopyrimidine derivatives |
| 12/28/2000 | WO2000078356A1 Injectable hyaluronate-sulfated polysaccharide conjugates |
| 12/28/2000 | WO2000078351A1 Osteogenesis promoters |
| 12/28/2000 | WO2000078332A2 Fish serine proteinases and their pharmaceutical and cosmetic use |
| 12/28/2000 | WO2000078324A1 The leaves of cajanus cajan(l.) millsp and extract, formulation and uses thereof |
| 12/28/2000 | WO2000078320A1 Cartilage enhancing food supplements and methods of preparing the same |
| 12/28/2000 | WO2000078318A1 Medicinal composition for oral administration |
| 12/28/2000 | WO2000078317A1 Integrin receptor antagonists |
| 12/28/2000 | WO2000078305A1 Remedies for arthrosis deformans |
| 12/28/2000 | WO2000061551A3 Pyrimidine-2-one derivatives as integrin receptor ligands |
| 12/28/2000 | WO2000061123A3 Compound preparation made of vitamin d metabolites or vitamin d analogues and an oestrogenic component for treating osteoporosis |
| 12/28/2000 | WO2000054780A3 Corticosteroid formulation |
| 12/28/2000 | WO2000043495A3 33 human secreted proteins |
| 12/28/2000 | WO2000043373A3 Kinase inhibitors |
| 12/28/2000 | WO2000034474A3 Growth factor homolog zvegf3 |
| 12/28/2000 | WO2000032776A3 Secreted amd transmembrane polypeptides and nucleic acids encoding the same |
| 12/28/2000 | WO1999052493A3 Compounds that inhibit the binding of integrins to their receptors |
| 12/28/2000 | DE19929410A1 New octapepide compounds as alpha v beta 6 integrin inhibitors useful for treating and diagnosing heart disease, tumors, osteoporosis, fibrosis, inflammation, infection and psoriasis |
| 12/28/2000 | DE19917705C1 Mittel zur Therapie von Hyperphosphatämie Means for therapy of hyperphosphatemia |
| 12/28/2000 | CA2377357A1 Fish serine proteinases and their pharmaceutical and cosmetic use |
| 12/28/2000 | CA2376155A1 Pharmaceutical composition for oral use |
| 12/28/2000 | CA2376081A1 Cysteinyl protease inhibitors |
| 12/28/2000 | CA2376077A1 Integrin receptor antagonists |
| 12/28/2000 | CA2375493A1 Human transport proteins |
| 12/28/2000 | CA2375407A1 Rna metabolism proteins |
| 12/28/2000 | CA2375275A1 Difuropyrone derivatives |
| 12/28/2000 | CA2375236A1 Anti-alphavbeta3 recombinant human antibodies, nucleic acids encoding same and methods of use |
| 12/28/2000 | CA2375182A1 5-cyano-2-aminopyrimidine derivatives |
| 12/27/2000 | EP1062321A1 Uses for humane non-autologous mesenchymal stem cells |
| 12/27/2000 | EP1062319A1 Vascular endothelial growth factor 2 |
| 12/27/2000 | EP1062236A1 31 human secreted proteins |
| 12/27/2000 | EP1062229A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 12/27/2000 | EP1062222A1 Serine peptidase modulators |
| 12/27/2000 | EP1062218A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 12/27/2000 | EP1062216A1 Inhibitors of phospholipase a2 |
| 12/27/2000 | EP1062214A1 Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and their use to reduce tnfa levels |
| 12/27/2000 | EP1062210A1 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors |
| 12/27/2000 | EP1062204A1 Modulators of protein tyrosine phosphatases (ptpases) |
| 12/27/2000 | EP1062199A1 Modulators of protein tyrosine phosphatases (ptpases) |
| 12/27/2000 | EP1061926A2 Heterocyclic compounds, their production and use as tachykinin receptor antagonists |
| 12/27/2000 | EP1061921A1 Vitronectin receptor antagonists |
| 12/27/2000 | EP1061917A1 Methods of inhibiting bone resorption |
| 12/27/2000 | EP1061912A1 Phenanthrofuran derivatives |
| 12/27/2000 | EP1061805A1 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 12/27/2000 | EP0821671B1 Arylsulfonyl hydroxamic acid derivatives as mmp and tnf inhibitors |
| 12/27/2000 | EP0821666B1 Derivatives of succinamide and their use as metalloproteinase inhibitors |
| 12/27/2000 | CN1278263A 2,3-diaryl-pyrazolo [1,5-B] pyridazines derivatives, their prepn. and use as cyclooxygenase 2 (cox-2) inhibitors |
| 12/27/2000 | CN1278250A Vitronectin receptor antagonists |
| 12/27/2000 | CN1278245A Malonic acid based matric metalloproteinase inhibitors |
| 12/27/2000 | CN1278244A Dipeptide nitriles |
| 12/27/2000 | CN1277869A Medicinal liquid for treating ligagmentum sacrotuberosum disease |
| 12/27/2000 | CN1277854A Capsule for treating bone diseaes |